KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Pfizer (PFE) Long-Term Debt Repayments (2016 - 2025)

Pfizer has reported Long-Term Debt Repayments over the past 17 years, most recently at $3.0 billion for Q4 2025.

  • Quarterly Long-Term Debt Repayments changed N/A to $3.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.8 billion through Dec 2025, changed N/A year-over-year, with the annual reading at $6.8 billion for FY2025, 200.31% up from the prior year.
  • Long-Term Debt Repayments was $3.0 billion for Q4 2025 at Pfizer, down from $3.8 billion in the prior quarter.
  • Over five years, Long-Term Debt Repayments peaked at $3.8 billion in Q2 2025 and troughed at $269.0 million in Q2 2023.
  • The 5-year median for Long-Term Debt Repayments is $1.3 billion (2023), against an average of $1.6 billion.
  • Year-over-year, Long-Term Debt Repayments crashed 83.28% in 2023 and then skyrocketed 364.68% in 2024.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $1.0 billion in 2021, then surged by 60.74% to $1.6 billion in 2022, then fell by 19.2% to $1.3 billion in 2023, then surged by 73.08% to $2.2 billion in 2024, then soared by 33.64% to $3.0 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Long-Term Debt Repayments are $3.0 billion (Q4 2025), $3.8 billion (Q2 2025), and $2.2 billion (Q3 2024).